Search Results 511-520 of 17513 for Assay

  1. Incidentally discovered adrenal masses and subclinical Cushing syndrome - Mayo Clinic

    We are in the process of developing a serum steroid assay aimed to discern false-positives from true clinically significant abnormalities in steroid production ...

  2. Clinical Trials - M6620 First in Human Study

    Subjects who are documented to be non-basaloid subtype using molecular profiling assay (e.g. PAM50 assay) prior to Screening; Subjects with unknown BRCA1 ...

  3. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

    ... assay: obtain tissue-based testing result confirming study eligibility (within first 4 weeks after enrollment). Atezolizumab. Molecular testing results from ...

  4. Copathologies in neurodegenerative disease - Neurobiology of Parkinson's Disease and Related Disorders: Pam J. McLean

    Researchers in the lab use proximity proteomics, proximity ligation assays, and cell and animal models to investigate how the different copathologies influence ...

  5. Publications - David G. Deckey, M.D. - Mayo Clinic

    Diagnostic accuracy of alpha-defensin elisa and lateral flow assays for periprosthetic joint infection: a systematic review and meta-analysis. Journal of ...

  6. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

    Peripheral blood MRD will be measured by the clonoSEQ® assay, with the threshold for MRD negativity set at a sensitivity level of 1 x 10-5 (uMRD5).

  7. Mayo Clinic researchers review the clinical potential of senolytic drugs on aging

    The platform, together with additional human cell assays, identified and confirmed a new category of senolytic drugs, which are called HSP90 inhibitors.

  8. Letrozole in Treating Postmenopausal Women with Ductal Carcinoma in Situ - Mayo Clinic

    Age < 55 years and one year or more amenorrhea, with an estradiol assay < 20pg/ml; Surgical menopause with bilateral oophorectomy (at least 28 days must ...

  9. Targeting Mesotrypsin in Breast, Prostate, Pancreatic and Lung Cancers - Proteases in Cancer Laboratory - Mayo Clinic Research

    These engineered inhibitors showed striking anti-cancer activity in physiologically relevant assays of breast cancer cell malignant growth, pancreatic cancer ...

  10. Overview - Muscle Physiology and Metabolism Laboratory - Mayo Clinic Research

    Our lab employs a growing number of cutting-edge assays to evaluate the function of mitochondria. Here, Xiaoyan Zhang, M.D., prepares bundles of ...